SuperGen to present at two upcoming investment conferences

Download PDF Copy

Editorial Checklist

Reviewed

Sep 3 2009

SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at two upcoming investment conferences.

Dr. James Manuso, and Mohammad Azab, M.D., Chief Medical Officer, will present at the Rodman & Renshaw Annual Global Investment Conference in New York on Thursday September 10, 2009 at 11:40 am ET.

Dr. Manuso will also present at the NewsMakers in the Biotech Industry investment conference in New York on Wednesday September 16, 2009 at 1:30 pm ET.

Live webcasts of both presentations will be available on the investor relations section of the Company's website at www.supergen.com. The webcasts will be archived for 90 days.

Source:

http://www.supergen.com

Posted in:

Tags: Cancer, Cell, C-section, DNA, Pharmaceuticals

Comments (0)

Download PDF Copy

Suggested Reading

Breakthrough reveals how DNA and RNA epigenetics work together to control genes

Breakthrough reveals how DNA and RNA epigenetics work together to control genes

OncoAssure announces clinical validation of prostate cancer test

OncoAssure announces clinical validation of prostate cancer test

New clinical trial aims to extend survival for bile duct cancer patients

New clinical trial aims to extend survival for bile duct cancer patients

A new AI tool for unlocking the secrets of spatial multi-omics in cancer

A new AI tool for unlocking the secrets of spatial multi-omics in cancer

PFAS in US water linked to increased cancer risk

PFAS in US water linked to increased cancer risk

Drug in breast cancer trials shows potential for treating blood cancers

Drug in breast cancer trials shows potential for treating blood cancers

Study explores cancer risks of hormonal contraceptives

Study explores cancer risks of hormonal contraceptives

New AI model offers hope for detecting brain cancer spread without surgery

New AI model offers hope for detecting brain cancer spread without surgery

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

PIN1 protein found to be a significant driver of bladder cancer